1. Home
  2. PCRX vs THRM Comparison

PCRX vs THRM Comparison

Compare PCRX & THRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PCRX
  • THRM
  • Stock Information
  • Founded
  • PCRX 2006
  • THRM 1991
  • Country
  • PCRX United States
  • THRM United States
  • Employees
  • PCRX N/A
  • THRM N/A
  • Industry
  • PCRX Biotechnology: Pharmaceutical Preparations
  • THRM Auto Parts:O.E.M.
  • Sector
  • PCRX Health Care
  • THRM Consumer Discretionary
  • Exchange
  • PCRX Nasdaq
  • THRM Nasdaq
  • Market Cap
  • PCRX 1.2B
  • THRM 997.7M
  • IPO Year
  • PCRX 2011
  • THRM 1993
  • Fundamental
  • Price
  • PCRX $23.63
  • THRM $34.54
  • Analyst Decision
  • PCRX Buy
  • THRM Buy
  • Analyst Count
  • PCRX 5
  • THRM 3
  • Target Price
  • PCRX $32.40
  • THRM $46.00
  • AVG Volume (30 Days)
  • PCRX 532.5K
  • THRM 192.2K
  • Earning Date
  • PCRX 11-05-2025
  • THRM 10-29-2025
  • Dividend Yield
  • PCRX N/A
  • THRM N/A
  • EPS Growth
  • PCRX N/A
  • THRM N/A
  • EPS
  • PCRX N/A
  • THRM 1.02
  • Revenue
  • PCRX $705,848,000.00
  • THRM $1,453,370,000.00
  • Revenue This Year
  • PCRX $7.36
  • THRM $1.64
  • Revenue Next Year
  • PCRX $10.07
  • THRM $3.31
  • P/E Ratio
  • PCRX N/A
  • THRM $33.81
  • Revenue Growth
  • PCRX 2.25
  • THRM N/A
  • 52 Week Low
  • PCRX $15.16
  • THRM $22.75
  • 52 Week High
  • PCRX $27.64
  • THRM $47.00
  • Technical
  • Relative Strength Index (RSI)
  • PCRX 32.49
  • THRM 45.92
  • Support Level
  • PCRX $24.31
  • THRM $33.24
  • Resistance Level
  • PCRX $26.05
  • THRM $36.09
  • Average True Range (ATR)
  • PCRX 0.76
  • THRM 1.17
  • MACD
  • PCRX -0.33
  • THRM -0.04
  • Stochastic Oscillator
  • PCRX 6.34
  • THRM 37.23

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.

About THRM Gentherm Inc

Gentherm Inc is an automotive parts manufacturer. The business activities of the group function through the Automotive and Medical segments. The vast majority of the firm's revenue comes from the Automotive segment, which includes automotive climate comfort systems, automotive cable systems, battery performance solutions, and automotive electronics and software systems. The medical segment is comprised of the results from the patient temperature management business in the medical industry. Its geographical segments are the United States, China, South Korea, Germany, Japan, the Czech Republic, and other countries.

Share on Social Networks: